In the present study, the authors employed mutation-specific droplet digital PCR (ddPCR) to analyze circulating ctDNA from plasma samples of patients with osteosarcoma, chondrosarcoma and Ewing Sarcoma, with the goal of characterizing mutation profiles in the IDH2 and TP53 genes. The gene discussed is IDH2; the disease is chondrosarcoma.